The Lancet Neurology in conversation with (The Lancet Group)
Explore every episode of The Lancet Neurology in conversation with
| Pub. Date | Title | Duration | |
|---|---|---|---|
| 22 Feb 2022 | Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2 | 00:07:55 | |
Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology. Continue this conversation on social! | |||
| 16 Mar 2022 | John Collinge on a treatment for CJD | 00:14:45 | |
John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology. Continue this conversation on social! | |||
| 06 Apr 2022 | Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's | 00:27:15 | |
Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition. Continue this conversation on social! | |||
| 13 Apr 2022 | Eva Feldman on advances in understanding ALS | 00:22:43 | |
Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology. Continue this conversation on social! | |||
| 13 May 2022 | Mark Hallett on functional neurological disorder | 00:08:43 | |
Mark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lancet Neurology, on functional neurological disorder, and talks about new subtypes of this disorder, diagnostic challenges, and how education is important. Continue this conversation on social! | |||
| 15 Jun 2022 | Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies | 00:18:52 | |
Sarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on Huntington’s disease published in the July issue of The Lancet Neurology: a Position Paper outlining a new classification of the disease, called the Huntington’s Disease Integrated Staging System, and a Personal View on potential disease-modifying therapies. Continue this conversation on social! | |||
| 13 Jul 2022 | Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy | 00:22:58 | |
Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology. Continue this conversation on social! | |||
| 10 Aug 2022 | Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy | 00:17:13 | |
Laurent Servais and Dora Markati (both from the University of Oxford, UK) discuss emerging therapies for Duchenne muscular dystrophy; their Review is published in the September issue of The Lancet Neurology. Continue this conversation on social! | |||
| 14 Sep 2022 | Jerome Siegel on sleep habits | 00:43:50 | |
Jerome Siegel (University of California, Los Angeles, CA, USA) discusses sleep research in hunter-gatherer populations and what we can learn from the sleep habits of various species; his Review is published in the October issue of The Lancet Neurology, which is the fourth paper in The Lancet’s Series on sleep and sleep disorders. Continue this conversation on social! | |||
| 18 Oct 2022 | Maeike Zijlmans on using biomarkers to tailor epilepsy surgery | 00:14:37 | |
Maeike Zijlmans (University Medical Center Utrecht, Utrecht, Netherlands) discusses recent research on tailoring of epilepsy surgery with biomarkers on intraoperative electrocorticography, and describes some of the challenges of this technique and what the future steps are for the field; the Article is published in the November issue of The Lancet Neurology. Continue this conversation on social! | |||
| 16 Nov 2022 | Axel Petzold on the diagnosis and classification of optic neuritis | 00:20:03 | |
Axel Petzold (National Hospital for Neurology and Neurosurgery and Moorfields Eye Hospital, London, UK, and Amsterdam University Medical Center, Amsterdam, Netherlands) discusses a Position Paper, published in the December issue of The Lancet Neurology, which sets out new criteria for the diagnosis and classification of optic neuritis. Continue this conversation on social! | |||
| 12 Dec 2022 | Beau Ances on amyloid biomarkers in Alzheimer’s | 00:11:34 | |
Beau Ances (Washington University in St Louis, MO, USA) discusses recent research on amyloid biomarkers in people with genetic forms of Alzheimer’s disease; his Article is published in the January issue of The Lancet Neurology. Continue this conversation on social! | |||
| 19 Jan 2023 | Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke | 00:08:45 | |
Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatment by non-contrast CT. This Fast-track Article is published in the February issue of The Lancet Neurology. Continue this conversation on social! | |||
| 16 Feb 2023 | Geraldine Dawson on advances in the prediction of autism during infancy | 00:24:34 | |
Geraldine Dawson (Duke University School of Medicine, NC, USA ) discusses the latest advances and ongoing challenges in prediction of autism during infancy. This Review is published in the March issue of The Lancet Neurology. Continue this conversation on social! | |||
| 15 Mar 2023 | Kerstin Hellwig on family planning considerations in MS | 00:14:24 | |
Kerstin Hellwig (Ruhr University Bochum, Bochum, Germany) discusses family planning considerations in multiple sclerosis. This Review is published in the April issue of The Lancet Neurology. Continue this conversation on social! | |||
| 13 Apr 2023 | Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation | 00:15:20 | |
Karen Duff and Connor Langworth-Green (University College London, London, UK) discuss tauopathies and the chronic effects of inflammation on this group of disorders. Their Personal View on this topic is published in the May issue of The Lancet Neurology. Continue this conversation on social! | |||
| 18 May 2023 | Andrew Cole on the complexities underlying epilepsy in people with glioblastoma | 00:18:38 | |
Andrew Cole (Massachusetts General Hospital Epilepsy Service, Boston, MA, USA) talks to Senior Editor Sarah Passey about the complexities underlying epilepsy in people with glioblastoma. His Review on this topic is published in the June issue of The Lancet Neurology. Continue this conversation on social! | |||
| 21 Jun 2023 | Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases | 00:17:20 | |
Benzi Kluger (University of Rochester Medical Center, Rochester, NY, USA), Claire Creutzfeldt (University of Washington, Seattle, WA, USA), and Malenna Sumrall (University of Colorado Anschutz Medical Campus, Aurora, CO, USA) join Jonathan Blott to discuss palliative care for individuals with neurological diseases, exploring the challenges and opportunities in enhancing the quality of life for those affected by neurological conditions. Their Review is published in the July issue of The Lancet Neurology. Continue this conversation on social! | |||
| 19 Jul 2023 | Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury | 00:14:34 | |
Stephen Strittmatter (Yale School of Medicine, CT, USA) discusses his first-in-human and randomised trial of a soluble Nogo-receptor-Fc decoy in patients with chronic cervical spinal cord injury. The Article is published in the August issue of The Lancet Neurology. Continue this conversation on social! | |||
| 16 Aug 2023 | William Jagust on amyloid β and cognition | 00:13:36 | |
William Jagust (University of California in Berkeley, CA, USA) talks to Senior Editor Sarah Passey about the complex pathway between amyloid β and cognition, and implications for therapy for people with Alzheimer’s disease. His Personal View on this topic is published in the September issue of The Lancet Neurology. Continue this conversation on social! | |||
| 20 Sep 2023 | Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis | 00:14:42 | |
Anthony Feinstein (University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Canada) discusses CogEx, a randomised trial of cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis. The Article is published in the October issue of The Lancet Neurology. Continue this conversation on social! | |||
| 20 Oct 2023 | Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations | 00:26:34 | |
Njideka Okubadejo and Mie Rizig join The Lancet Neurology to discuss their comprehensive genome-wide assessment in African and African admixed individuals with the aim of developing a better understanding of the genetic architecture of Parkinson's disease in these underserved populations. Continue this conversation on social! | |||
| 15 Nov 2023 | Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage | 00:24:09 | |
Rustam Al-Shahi Salman joins Senior Editor Sarah Passey to discuss the COCROACH meta-analysis findings, published in the December issue of The Lancet Neurology, of the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage. Continue this conversation on social! | |||
| 13 Dec 2023 | Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury | 00:18:24 | |
Cecilia Åkerlund and David Nelson join The Lancet Neurology to discuss their research on clinical variables that might distinguish how the disease process progresses in people with traumatic brain injury. The Article is published in the January issue of The Lancet Neurology. Continue this conversation on social! | |||
| 22 Jan 2024 | Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy | 00:21:45 | |
Marianne Chapleau and Gil Rabinovici join Senior Editor Sarah Passey to discuss their research on posterior cortical atrophy. The Article is published in the February issue of The Lancet Neurology. Continue this conversation on social! | |||
| 14 Feb 2024 | Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders | 00:12:20 | |
Giovanni Frisoni joins The Lancet Neurology to discuss new European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders. The Personal View is published in the March issue of The Lancet Neurology. Continue this conversation on social! | |||
| 14 Mar 2024 | Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system | 00:25:18 | |
Jaimie Steinmetz and Theo Vos from the Institute for Health Metrics and Evaluation, and Katrin Seeher and Tarun Dua from WHO, join Heather Brown and Lauren Southwell to discuss new data on the global, regional, and national burden of disorders affecting the nervous system. The Article is published in the April issue of The Lancet Neurology. Continue this conversation on social! | |||
| 15 Apr 2024 | Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy | 00:23:28 | |
Jacqueline French and Jacob Pellinen join Senior Editor Sarah Passey to discuss recent progress made in the diagnosis of epilepsy and challenges that remain. Their Review on this topic is published in the May issue of The Lancet Neurology. Continue this conversation on social! | |||
| 15 May 2024 | Sanjay Sisodiya on climate change and brain health | 00:20:48 | |
Sanjay Sisodiya joins The Lancet Neurology to discuss the potential effects of climate change on brain health. The Personal View is published in the June issue of The Lancet Neurology. Continue this conversation on social! | |||
| 12 Jun 2024 | Glenn Nielsen on specialist physiotherapy for people with functional motor disorder | 00:15:28 | |
Dr Glenn Nielsen joins Lauren Southwell to discuss the Physio4FMD trial of specialist physiotherapy for people with functional motor disorder in England and Scotland. This Article is published in the July issue of The Lancet Neurology. Continue this conversation on social! | |||
| 17 Jul 2024 | Adrian Owen on detecting awareness after acute brain injury | 00:17:19 | |
Dr Adrian Owen joins Sarah Passey to chat about a his Personal View, published in the August 2024 issue of The Lancet Neurology, about detecting awareness after an acute brain injury. Continue this conversation on social! | |||
| 14 Aug 2024 | Alex Iranzo on sleep and Parkinson's disease | 00:16:44 | |
Dr Alex Iranzo joins The Lancet Neurology to discuss his recent Review on the association between sleep disorders and Parkinson's disease. The Review is published in the August issue of The Lancet Neurology. Continue this conversation on social! | |||
| 18 Sep 2024 | Jorge Correale and Lilyana Amezcua on differential diagnosis of multiple sclerosis | 00:19:00 | |
Prof Jorge Correale and Dr Lilyana Amezcua talk to The Lancet Neurology about their Personal View papers, published in the October 2024 issue, on the differential diagnosis of multiple sclerosis in regions outside North America and Western Europe and in people from minority ethnic or racial backgrounds in North America, northern Europe, and Australasia. Continue this conversation on social! | |||
| 16 Oct 2024 | Suvankar Pal on the motor neuron disease trial MND-SMART | 00:17:50 | |
Professor Suvankar Pal (University of Edinburgh) joins Sarah Passey (Senior Editor at The Lancet Neurology) to discuss the first findings from the MND-SMART trial of treatments for motor neuron disease. The Article is published in the November issue of The Lancet Neurology. Continue this conversation on social! | |||
| 20 Nov 2024 | Florian Krismer and Elizabeth Coon on multiple system atrophy | 00:17:14 | |
Florian Krismer (Innsbruck Medical University) and Elizabeth Coon (Mayo Clinic) join Sarah Passey (The Lancet Neurology) to discuss their Review paper on multiple system atrophy, which is published in the December issue of The Lancet Neurology. Continue this conversation on social! | |||
| 18 Dec 2024 | The Lancet Neurology Editors on advances in neurology in 2024 | 00:17:30 | |
The Lancet Neurology Editors take a look back at advances in neurology in 2024, as highlighted by experts in a series of Round-ups published in the January issue. Continue this conversation on social! | |||
| 22 Jan 2025 | Elizabeth Finger on oxytocin for apathy in frontotemporal dementia | 00:18:13 | |
In this podcast, linked to the February 2025 issue of The Lancet Neurology, Elena Becker-Barroso (Editor-in-Chief) chats to Elizabeth Finger (Western University, London, ON, Canada) about the FOXY trial of oxytocin for apathy in people with frontotemporal dementia. Continue this conversation on social! | |||
| 19 Feb 2025 | Michael Tymianski on neuroprotection in stroke | 00:24:47 | |
Sarah Passey (The Lancet Neurology) is joined by Michael Tymianski (University Health Network, Toronto, Canada) to discuss an Article in the March issue reporting a meta-analysis looking at neuroprotection in stroke and what can be learnt for future research. Read the full article: Continue this conversation on social! | |||
| 19 Mar 2025 | Marialuisa Gandolfi on the management of chronic pain in Parkinson's disease | 00:12:13 | |
In this podcast, linked to the April 2025 issue of The Lancet Neurology, Laura Hart (Deputy Editor) chats to Marialuisa Gandolfi (University of Verona in Italy) about advances in the classification and management of pain in Parkinson’s disease. Continue this conversation on social! | |||
| 16 Apr 2025 | Wayne Feng on stroke rehabilitation using brain stimulation and constraint-induced movement therapy | 00:19:22 | |
Increasing numbers of people are surviving stroke but with motor impairments that can contribute substantially to long-term disability. Transcranial direct current stimulation has shown promise in reducing motor impairment when combined with rehabilitation therapy. Sarah Passey talks to Wayne Feng (Duke University School of Medicine, Durham, NC, USA) about his latest trial, TRANSPORT2, which assesses transcranial direct current stimulation in combination with modified constraint-induced movement therapy. Read the full article: Continue this conversation on social! | |||
| 21 Oct 2020 | PET imaging of inflammation in neurological and psychiatric disorders | 00:09:11 | |
Robert Innis discusses his work on measuring neuroinflammation using PET imaging. Continue this conversation on social! | |||
| 24 Nov 2020 | Prednisone in short-term prevention of cluster headache | 00:09:09 | |
Mark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache. Continue this conversation on social! | |||
| 22 Dec 2020 | Genetic risk factors for sCJD | 00:23:02 | |
Emma Jones and Simon Mead discuss their article in The Lancet Neurology, identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease. Continue this conversation on social! | |||
| 20 Jan 2021 | Spinal cord injury and degenerative cervical myelopathy | 00:19:33 | |
Professor Michael Fehlings discusses the implications of his two papers in the Jan 2021 issue of The Lancet Neurology. Continue this conversation on social! | |||
| 17 Feb 2021 | Peter Rothwell on asymptomatic carotid stenosis and stroke | 00:09:25 | |
Peter Rothwell (Oxford University) discusses his research, found in our new issue, on asymptomatic carotid stenosis and stroke. Continue this conversation on social! | |||
| 17 Mar 2021 | Anne MacGregor on menstrual migraine | 00:12:50 | |
Anne MacGregor discusses her recent Review of menstrual migraine, and explains why the problem needs greater recognition. Continue this conversation on social! | |||
| 21 Apr 2021 | Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS | 00:08:36 | |
Henk-Jan Westeneng discusses his new work on the causal effects of pre-symptomatic lifestyle on ALS. Continue this conversation on social! | |||
| 19 May 2021 | Geert Jan Biessels on predicting post-stroke cognitive impairment | 00:07:59 | |
Geert Jan Biessels (University Medical Centre Utrecht) discusses his research, published in our June issue, on using strategic infarct locations to predict post-stroke cognitive impairment. Continue this conversation on social! | |||
| 16 Jun 2021 | Doug Turnbull on mitochondrial diseases in adults | 00:20:12 | |
Doug Turnbull (University of Newcastle) discusses mitochondrial diseases in adults, which are reviewed in the July issue of The Lancet Neurology, and explains how important these diseases are for neurologists. Continue this conversation on social! | |||
| 21 Jul 2021 | Irene Cortese on the difficulties of designing clinical trials | 00:09:58 | |
Irene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifocal leukoencephalopathy and talks about a pilot study of virus-specific T cells for treatment of this population, published in the August issue of The Lancet Neurology. Continue this conversation on social! | |||
| 18 Aug 2021 | Adam Boxer on tau biomarkers | 00:12:13 | |
Adam Boxer (University of California, San Francisco) discusses his research, published in August issue of The Lancet Neurology, on diagnostic performance of tau biomarkers in neurodegenerative diseases. Continue this conversation on social! | |||
| 15 Sep 2021 | Priya Palta on blood pressure control and cognitive decline | 00:16:47 | |
Priya Palta (Columbia University, New York) explains the importance of blood pressure control in the prevention of cognitive decline. Her Review, published in the October issue of The Lancet Neurology, provides an update of the mounting evidence that links hypertension with dementia risk. Continue this conversation on social! | |||
| 20 Oct 2021 | Antonio Uccelli on stems cells for MS | 00:18:08 | |
Antonio Uccelli (University of Genoa) discusses his research, published in the November issue of The Lancet Neurology, on the therapeutic use of mesenchymal stem cells for multiple sclerosis. Continue this conversation on social! | |||
| 17 Nov 2021 | Olivier Rascol on amantadine for patients with movement disorders | 00:28:27 | |
Olivier Rascol (Toulouse University, France) discusses the uses of amantadine in the treatment of patients with movement disorders, which are the focus of his Personal View in the December issue of The Lancet Neurology. Continue this conversation on social! | |||
| 20 Dec 2021 | Alberto Costa on memantine in adolescents and young adults with Down syndrome | 00:15:14 | |
Alberto Costa (Case Western Reserve University, Cleveland, OH, USA) discusses his study on the use of memantine in adolescents and young adults with Down syndrome, which is published in the January issue of The Lancet Neurology. Continue this conversation on social! | |||
| 19 Jan 2022 | Giuseppe Citerio on frailty and TBI | 00:09:35 | |
Giuseppe Citerio (University of Milano-Bicocca, Milan, Italy) discusses the implications of a study from the CENTER-TBI project of the effect of frailty on 6-month outcome after traumatic brain injury, which is published in the February issue of The Lancet Neurology. Continue this conversation on social! | |||
| 13 Sep 2016 | Sleep disorders in children: The Lancet Neurology: September 12, 2016 | 00:06:08 | |
Dr. Kiran Maski discusses insomnia, parasomnia, and narcolepsy in children. Continue this conversation on social! | |||
| 12 Oct 2016 | Ventilation for ALS patients: The Lancet Neurology: November 2016 | 00:09:40 | |
Professor Thomas Similowski discusses his surprising study on the effectiveness of non-invasive ventilation for patients with amyotrophic lateral sclerosis. Continue this conversation on social! | |||
| 22 Oct 2016 | Autosomal dominant familial Alzheimer's disease: The Lancet Neurology: 21 October 2016 | 00:21:15 | |
Randall Bateman and Nick Fox discuss what they've learned from their papers on Alzheimer's disease. Continue this conversation on social! | |||
| 07 Nov 2017 | Traumatic Brain Injury: The Lancet Neurology: November 7, 2017 | 00:37:40 | |
Andrew Maas and David Menon, lead authors, discuss The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden. Continue this conversation on social! | |||
| 09 Aug 2017 | Genetic variants and Huntington's: The Lancet Neurology: September 2017 | 00:18:40 | |
Lesley Jones and Sarah Tabrizi talk about their work on the identification of genetic markers associated with the progression of Huntington's disease. Continue this conversation on social! | |||
| 09 May 2017 | Neurological consequences of obesity: The Lancet Neurology: May 9, 2017 | 00:09:53 | |
Eva Feldman discusses the neurological consequences of obesity. Continue this conversation on social! | |||
| 11 Oct 2017 | TDP-43 and Alzheimer's disease: The Lancet Neurology: November 2017 | 00:09:09 | |
Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease. Continue this conversation on social! | |||
| 12 Jul 2017 | Simvastatin and MS: The Lancet Neurology: August 2017 | 00:04:50 | |
Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis. Continue this conversation on social! | |||
| 13 Sep 2017 | Biomarkers in stroke recovery: The Lancet Neurology: October 2017 | 00:07:00 | |
Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke. Continue this conversation on social! | |||
| 14 Jun 2017 | Progressive supranuclear palsy: The Lancet Neurology: July 2017 | 00:24:27 | |
Adam Boxer offers an overview of the latest on diagnosis and treatment for progressive supranuclear palsy. Continue this conversation on social! | |||
| 16 Dec 2017 | GWAS on dementia with Lewy bodies: The Lancet Neurology: January, 2018 | 00:06:18 | |
Jose Bras discusses his study of the genetic architecture of dementia with Lewy bodies. Continue this conversation on social! | |||
| 24 Feb 2017 | Neurodegenerative disease: The Lancet Neurology: February 23, 2017 | 00:21:10 | |
Marc Diamond discusses his Personal View on the prion model for progression and diversity of neurodegenerative diseases. Continue this conversation on social! | |||
| 30 Apr 2018 | Antiepileptic drugs and risk of congenital malformation | 00:07:57 | |
Torbjörn Tomson discusses the issue of antiepileptic drugs during pregnancy and the risk of major congenital malformations. Continue this conversation on social! | |||
| 14 Feb 2018 | Seizure detection and reporting in epilepsy: The Lancet Neurology: February 13, 2018 | 00:06:03 | |
Christian Elger discusses the diagnostic challenges in epilepsy with the detection and reporting of seizures. Continue this conversation on social! | |||
| 19 Jan 2018 | MS McDonald criteria revisions: The Lancet Neurology: February 2018 | 00:09:01 | |
Jeffrey Cohen joins us to talk about the process of updating and revising the McDonald criteria for diagnosis of MS. Continue this conversation on social! | |||
| 24 Jul 2018 | Autoimmune encephalitis after herpes simplex encephalitis | 00:10:29 | |
Josep Dalmau joins The Lancet Neurology to discuss recognition and outcomes of autoimmune encephalitis after herpes simplex encephalitis. Continue this conversation on social! | |||
| 16 Jun 2018 | Network imaging biomarkers | 00:20:21 | |
David Eidelberg and Katharina Schindelbeck join The Lancet Neurology to explain their new review of the applications of network imaging biomarkers in Parkinson's disease. Continue this conversation on social! | |||
| 04 May 2018 | Progressive multifocal leukoencephalopathy | 00:19:45 | |
Eugene Major and David Clifford join The Lancet Neurology to discuss their review of pathogenesis and treatments for progressive multifocal leukoencephalopathy. Continue this conversation on social! | |||
| 22 Nov 2018 | Stroke–heart syndrome | 00:10:40 | |
In the latest podcast from The Lancet Neurology, Jan Scheitz discusses the development of stroke–heart syndrome. Continue this conversation on social! | |||
| 02 Oct 2018 | Thrombectomy for ischaemic stroke | 00:08:49 | |
Bruce Campbell joins The Lancet Neurology to discuss his systematic review of the HERMES collaboration. Continue this conversation on social! | |||
| 16 Oct 2018 | Epileptic seizures | 00:11:42 | |
Mark Cook and Phillippa Karoly join The Lancet Neurology to discuss their retrospective study of cyclical patterns in epileptic seizures. Continue this conversation on social! | |||
| 18 Sep 2018 | Cerebral white matter demyelination in multiple sclerosis | 00:15:30 | |
Bruce Trapp and Daniel Ontaneda discuss their retrospective study investigating cortical neuronal loss and cerebral white-matter demyelination in mulitple sclerosis. Continue this conversation on social! | |||
| 22 Jan 2019 | Frailty and Alzheimer's | 00:12:31 | |
Lindsay Wallace and Kenneth Rockwood join The Lancet Neurology to talk about their work on the association between frailty and the onset of Alzheimer's disease. Continue this conversation on social! | |||
| 14 Mar 2019 | Role of astroglia in Alzheimer's disease | 00:15:04 | |
Amaia Arranz and Bart De Strooper discuss their Review on the role of astroglia in Alzheimer's disease. Continue this conversation on social! | |||
| 12 Apr 2019 | Next-generation sequencing and clinical neurology | 00:07:47 | |
Brent Fogel talks to The Lancet Neurology about his work on large-scale genomic analysis. Continue this conversation on social! | |||
| 13 Feb 2019 | Sleep disturbance and dementia risk | 00:11:11 | |
Michael Irwin (University of California, Los Angeles, USA) discusses a Review concerning potential links of sleep disturbance and possible increased risk of Alzheimer's disease dementia. Continue this conversation on social! | |||
| 21 May 2019 | Stroke genetics | 00:16:37 | |
Martin Dichgans discusses advancements in the field of stroke genetics. Continue this conversation on social! | |||
| 06 Nov 2019 | The global burden of neurological conditions | 00:37:11 | |
Andrea Winkler discusses the global burden caused by stroke, epilepsy, dementia, and neuroinfections, and what low- and middle-income countries can do. Continue this conversation on social! | |||
| 13 Sep 2019 | Blood pressure and brain structure | 00:10:10 | |
Jonathan Schott discusses the associations between blood pressure across adulthood and late-life brain structure and pathology. Continue this conversation on social! | |||
| 17 Jun 2020 | Management of Parkinson's disease | 00:10:43 | |
Bas Bloem chats about his new research into a network model for reshaping chronic neurological care for patients with Parkinson's disease. Continue this conversation on social! | |||
| 26 May 2020 | Optimal time to treat Huntington's Disease | 00:12:55 | |
Sarah Tabrizi discusses her new research into analysing the early onset of Huntington's Disease. Continue this conversation on social! | |||
| 31 Jul 2020 | Advances in understanding of Rett syndrome | 00:20:44 | |
Huda Zoghbi discusses the prospects for future therapies in Rett syndrome. Continue this conversation on social! | |||
| 04 Sep 2020 | Neurological associations of COVID-19 | 00:11:23 | |
Tom Solomon discusses his Rapid Review on neurologically-associated COVID-19 problems, in The Lancet Neurology. Continue this conversation on social! | |||
| 28 Apr 2020 | Evidence-based support for autistic people across the lifespan | 00:21:14 | |
Meng-Chuan Lai discusses the current evidence base for supporting autistic people. Continue this conversation on social! | |||
| 19 Mar 2020 | Oral immunomodulating therapies in relapsing MS | 00:11:30 | |
Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis. Continue this conversation on social! | |||
| 14 Mar 2008 | The Lancet Neurology: March 14, 2008 | 00:05:06 | |
Editor Helen Frankish discusses highlights from the April issue: including the EPITHET study of alteplase treatment 3-6 hours after a stroke, and donepezil treatment in patients with CADASIL, a genetic form of vascular dementia. Continue this conversation on social! | |||
| 14 Jul 2008 | The Lancet Neurology: July 14, 2008 | 00:08:09 | |
Helen Frankish discusses biomarkers for indications of dementia, and other highlights from the August issue. Continue this conversation on social! | |||
| 22 Jan 2008 | The Lancet Neurology: January 22, 2008 | 00:05:14 | |
Imaging of amyloid β in Alzheimer's disease with a novel PET tracer Amyloid β (Aβ) deposits can be imaged by PET, but most Aβ PET ligands are not suitable for clinical diagnosis of Alzheimer's disease (AD). To test the effectiveness of a new Aβ PET ligand, 18F-BAY94-9172, Christopher Rowe and colleagues compared its binding with Aβ deposition in patients with AD, individuals with frontotemporal lobar degeneration, and healthy controls. Helen Frankish discusses the study in this month's podcast, and highlights the editorial concerning the possible tagging of individuals with AD. Continue this conversation on social! | |||
| 17 Dec 2007 | The Lancet Neurology: December 17, 2007 | 00:06:37 | |
Epilepsy in children encompasses several syndromes that have different prognoses but are all characterised by a predisposition to recurrent seizures; therefore, treatment has to be tailored to the individual. Any treatment regimen for children with epilepsies should have rational goals, take into account the additional morbidities that are commonly found in these patients. Continue this conversation on social! | |||
| 16 Jun 2008 | The Lancet Neurology: June 16, 2008 | 00:16:04 | |
The International LRRK2 Consortium, which includes investigators in 21 centres, has collected data from almost 20000 patients with Parkinson's disease carrying mutations in the LRRK2 gene. The Lancet Neurology editor Elena Becker-Barroso and Daniel Healy, the corresponding author on their first report, summarises the findings and their implications in clinical practice in a podcast. Continue this conversation on social! | |||
| 19 May 2008 | The Lancet Neurology: May 19, 2008 | 00:06:38 | |
Editor Helen Frankish discusses highlights from the June issue: a randomised trial showing the efficacy of a ketogenic diet to protect against childhood epilepsy; and a trial with phase II results for the Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease. Continue this conversation on social! | |||
| 18 Feb 2008 | The Lancet Neurology: February 18, 2008 | 00:05:27 | |
Editor Helen Frankish discusses highlights from the March issue: including research Articles about a genetic clue to the cause of dystonia, a neurological disorder relating to Parkinson's disease; and a study identifying older age (68 years) as a risk factor for stroke among people given stenting rather than Endarterectomy to unblock the carotid artery. Continue this conversation on social! | |||
| 18 Apr 2008 | The Lancet Neurology: April 18, 2008 | 00:08:21 | |
Editor Helen Frankish discusses highlights from the May issue: results from the INTERACT trial showing how intensive blood pressure lowering could be beneficial for people who have had intra cranial haemorrhage; also discussion of a genetic study identifying a gene mutation involved in amyloid lateral sclerosis, and a review of stroke in children. Continue this conversation on social! | |||
| 13 Oct 2008 | The Lancet Neurology: October 13, 2008 | 00:08:28 | |
In this month's Lancet Neurology Podcast, Editor Helen Frankish discusses two research articles: one on the treatment of hemicrania continua, and another on perception of pain in a minimally conscious state. Also discussed is a review on sudden unexpected death in epilepsy. Continue this conversation on social! | |||